Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne

Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion

AsiaOne Health News, Get the Latest Health Breaking News at AsiaOne

Spotify says it will add content advisory to podcasts that discuss Covid-19, Digital News - AsiaOne

Digitrio promises to deliver Faster, Better SEO using the Pareto Principle, Business News - AsiaOne

McLaren boss says F1 budget cap breach amounts to cheating, World News - AsiaOne

Tesla is apparently Singapore's most hated brand, Lifestyle News - AsiaOne

A new winter-themed Minecraft world for learning English arrives, Business News - AsiaOne

Canon bolsters its colour production digital press portfolio with the new imagePRESS V900 series, Business News - AsiaOne

iQIYI Unveils 282 New Titles at 2023 iJOY Conference, Prioritizing Relatable Content for Ordinary People, Business News - AsiaOne

About ready to kill somebody': Guy Pearce struggled to cope with fame and success after making switch to Hollywood, Entertainment News - AsiaOne

Reunite in Nuanor! Pre-register Revelation M and get ready for the Close Beta to unveil endless surprises!, Business News - AsiaOne

Bayer stops blood thinner drug trial for lack of effect in major setback

Qualitas To Provide COVID-19 Mobile Home Sampling, Business News - AsiaOne